A visit to any private or public hospital reveals a sad state of affairs. Many women are in the throes of their lives as the ...

TruScreen Group Ltd. (AU:TRU) has released an update. TruScreen Group Ltd. has announced that a new study published by Germany’s Springer Nature found their cervical cancer screening technology to be ...

Over 800 thousand people are diagnosed with liver cancer every year worldwide, and it accounts for more than 700 thousand ...

Clinicians are hopeful the new approach will give people with aggressive cervical cancer additional options for treatment, particularly those who face barriers to healthcare. Cervical cancer ...

Cervical cancer, a key cause of cancer-related deaths among Indian women, can be prevented and cured through early screening and vaccination. India records 123,000 new cases and over 77,000 deaths ...

How do we interpret these results when making treatment decisions? INTERLACE addresses the relatively lower risk locally advanced cervical cancer group when compared to KEYNOTE-A18 (no patients with ...

The star was diagnosed with cervical cancer at the age of 36 in 2021, which led to her undergoing a radical hysterectomy. This operation resulted in her developing lymphoedema, a condition that ...

The star was diagnosed with cervical cancer at the age of 36 in 2021, which led to her undergoing a radical hysterectomy. This operation resulted in her developing lymphoedema, a condition that ...

THURSDAY, Oct. 17, 2024 (HealthDay News) -- In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of chemotherapy to standard treatment cuts ...

Induction chemotherapy followed by chemoradiotherapy improves 5-year overall survival rates in advanced cervical cancer from 72% to 80%. The treatment also enhances 5-year progression-free ...

Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in a significant increase in survival rates, a new study shows. The study ...